Short report: Contribution of quantitative real-time polymerase chain reaction to follow-up of visceral leishmaniasis patients treated with meglumine antimoniate

American Journal of Tropical Medicine and Hygiene

Volumn 81, Issue 6, 2009, Pages 1004-1006

  Aoun, Karim ^a,b   Chouihi, Emira ^a   Amri, Fethi ^c   Alaya, Nissaf Ben ^b   Raies, Ali ^d   Mary, Charles ^e   Bouratbine, Aida ^a,b  

^a Research Laboratory of Emerging Parasitic Diseases LR 05 SP 03   (Tunisia)

^b PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^c Department of Paediatrics ^*  (Tunisia)

^d Tunisian University of Sciences   (Tunisia)

^e TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; MEGLUMINE ANTIMONATE; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND; PROTOZOAL DNA;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FOLLOW UP; HUMAN; INFANT; NEWBORN; PARASITEMIA; PRESCHOOL CHILD; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TUNISIA; VISCERAL LEISHMANIASIS; BLOOD; POLYMERASE CHAIN REACTION;

ANTIPROTOZOAL AGENTS; DNA, PROTOZOAN; FOLLOW-UP STUDIES; HUMANS; LEISHMANIASIS, VISCERAL; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; POLYMERASE CHAIN REACTION;

EID: 73949089247     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.09-0285     Document Type: Article

References (12)

1. Abdelmoula MS, M'Hamdi Z, Amri F.Tebib N, BenTurkia F, Ben Dridi MF, 2003. La leishmaniose viscérale chez l'enfant: facteurs pronostiques. Tunis Med 81: 535-539.
2. Bouratbine A, Aoun K, Chahed MD, Ben Ismail R, 1998. Données épidémiologiques sur la leishmaniose viscérale infantile en Tunisie en 1993. Med Mal Infect 28: 446-447.
3. Aoun K, Bouratbine A, 2008. Leishmaniasis. Rakel ER, Bope ET, eds. Conn's Current Therapy 2008. Philadelphia: Saunders Elsevier, 94-98.
4. Mary C, Farault F, Lascombe L, Dumon H, 2004. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol 42: 5249-5255.
5. Antinori S, Calattini S, Piolini R, Longhi E, Bestetti G, Cacsio A, Parravicini C, Gorbellini M,2009. Is real-time PCR more useful than a conventional PCR for the clinical management of leishmaniasis. Am J Trop Med Hyg 81: 46-51.
6. Mary C, Farault F, Droguoul MP, Xeridat B, Scleinitz N, Cuisenier, Dumon H., 2006. Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up. Am J Trop Med Hyg 75: 858-863.
7. Rioux JA, Lanotte G, Serres E, Pratlong F, Bastien P, Périères J, 1990. Taxonomy of Leishmania: use of isoenzymes and suggestion for a new classification. Ann Parasitol Hum Comp 65: 111-125.
8. Desjeux P, 2005. Therapeutic options for visceral leishmaniasis. Med Mal Infect 35: 74-76.
9. Cascio A, Calattini S, Colomba C, Scalmonia C, Galazzi M, Pizzuto M, Camilli R, Gramiccia M,Titone L, Gorbellini M, Antinori S, 2002. Polymerase chain reaction in the diagnosis and prognosis of Mediterranean visceral leishmaniasis in immunocompetent children. Pediatrics 109: E27.
10. Cruz I, Chicharro C, Nieto J, Bailo B, Canavate C, Figueras MC, Alvar J, 2006. Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis. J Clin Microbiol 44: 2343-2347.
11. Gradoni L, Gramiccia M, Pettoello M, Di Martino L.Nocerino A, 1987. A new Leishmania infantum enzymatic variant, agent of visceral leishmaniasis case unresponsive to drugs. Trans R Soc Trop Med Hyg 81: 927-928.
12. Faraut-Gambarelli F, Piarroux R, Deniau M, Giusiano B, Marty P, Michel G, Faugère B, Dumon H, 1997. In vivo and in vitro resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother 41: 827-830.